Helmut Greim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Helmut Greim has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Colin Berry
Prof. (emeritus) of Pathology, Queen Mary, London, UK
3 shared publications - Corrado Lodovico Galli
Università degli Studi di Milano
3 shared publications - Gio Batta Gori
Regulatory Toxicology and Pharmacology, Bethesda, MD, USA
3 shared publications - Hans Wj. Marquardt
Experimental and Clinical Toxicology University of Hamburg Medical School Hambug, Germany
3 shared publications - Herman Autrup
Institute of Public Health, University of Aarhus, Aarhus, Denmark
3 shared publications - Hiroshi Yamazaki
Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Tokyo, Japan
3 shared publications
Latest Publications
- 13 August 2019
- Published by Springer Nature in Archives of Toxicology
- Vol. 93 (9) , 2483-2490
Diesel engine emissions: are they no longer tolerable?
Emissions from diesel engines contain several hundred chemical compounds, which are emitted partly as gas and partly as particles. The composition of diesel exhaust and its concentrations in air has changed significantly over time, to the extent that now there is a distinction between "traditional" and "new technology" diesel emissions. New technology diesel engines comply with emissions from EURO 3 vehicles and higher. Starting with EURO 5, a significant further reduction of particle emissions has been achieved by increased temperature, which, however, lead to increased emissions of NOx and exceeded the NO2 emission limit. To overcome this problem, some car manufacturers installed illegal software that detected the vehicle test bench operation, resulting in low emissions during the test cycle. Detection of such devices in 2015 led to the "Diesel scandal". In 2017 the worldwide harmonized light vehicles test procedure (WLTP) was introduced for new cars, which simulates emissions under different driving conditions. It became mandatory for certification of all new vehicles by September 2018. In addition, fleet CO2 emissions have been introduced for all cars, requiring that by 2020 95% of each manufacturer's passenger car must meet the CO2 emission target of 95 mg/km, and by 2021 100% of the fleet. All these regulations significantly reduced the emissions of diesel- and gasoline-driven cars, which since the introduction of the EURO 6 regulation in 2014 are almost similar for both. Since the energy efficiency of diesel motors is up to 20% higher than that of gasoline-driven cars resulting in up to 20% lower CO2 emission, there is no reason to question the future use of diesel engines. These regulations apply for new cars. However, air concentrations at sampling points close to streets with high traffic still exceed the limit values especially for NO2. In several cities this led to restrictions for passenger cars of EURO 5 and below. Since concentrations close to streets are not relevant to evaluate the long-term exposure of the population, these measures are highly debatable.
- 13 August 2019
- Published by Springer Nature in Archives of Toxicology
- Vol. 93 (9) , 2483-2490
Diesel engine emissions: are they no longer tolerable?
Emissions from diesel engines contain several hundred chemical compounds, which are emitted partly as gas and partly as particles. The composition of diesel exhaust and its concentrations in air has changed significantly over time, to the extent that now there is a distinction between "traditional" and "new technology" diesel emissions. New technology diesel engines comply with emissions from EURO 3 vehicles and higher. Starting with EURO 5, a significant further reduction of particle emissions has been achieved by increased temperature, which, however, lead to increased emissions of NOx and exceeded the NO2 emission limit. To overcome this problem, some car manufacturers installed illegal software that detected the vehicle test bench operation, resulting in low emissions during the test cycle. Detection of such devices in 2015 led to the "Diesel scandal". In 2017 the worldwide harmonized light vehicles test procedure (WLTP) was introduced for new cars, which simulates emissions under different driving conditions. It became mandatory for certification of all new vehicles by September 2018. In addition, fleet CO2 emissions have been introduced for all cars, requiring that by 2020 95% of each manufacturer's passenger car must meet the CO2 emission target of 95 mg/km, and by 2021 100% of the fleet. All these regulations significantly reduced the emissions of diesel- and gasoline-driven cars, which since the introduction of the EURO 6 regulation in 2014 are almost similar for both. Since the energy efficiency of diesel motors is up to 20% higher than that of gasoline-driven cars resulting in up to 20% lower CO2 emission, there is no reason to question the future use of diesel engines. These regulations apply for new cars. However, air concentrations at sampling points close to streets with high traffic still exceed the limit values especially for NO2. In several cities this led to restrictions for passenger cars of EURO 5 and below. Since concentrations close to streets are not relevant to evaluate the long-term exposure of the population, these measures are highly debatable.
- 29 October 2018
- Published by Springer Nature in Archives of Toxicology
- Vol. 92 (12) , 3597-3598
My experiences with the MAK Commission: a response to a recent editorial
- 29 October 2018
- Published by Springer Nature in Archives of Toxicology
- Vol. 92 (12) , 3597-3598
My experiences with the MAK Commission: a response to a recent editorial
- 1 October 2018
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 98, 199-208
Human relevance of follicular thyroid tumors in rodents caused by non-genotoxic substances
- 1 October 2018
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 98, 199-208
Human relevance of follicular thyroid tumors in rodents caused by non-genotoxic substances
- Open Access
- 11 July 2018
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 97, A1-A3
Obfuscating transparency?
- 11 July 2018
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 97, A1-A3
Open AccessObfuscating transparency?
- 1 December 2016
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 82, A1-A2
Whither the impending european regulation of presumed endocrine disruptors?
- 1 December 2016
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 82, A1-A2
Whither the impending european regulation of presumed endocrine disruptors?
- 1 September 2016
- Published by Elsevier in Toxicology
- Vol. 371, 12-16
Upholding science in health, safety and environmental risk assessments and regulations
- 1 September 2016
- Published by Elsevier in Toxicology
- Vol. 371, 12-16
Upholding science in health, safety and environmental risk assessments and regulations
- Open Access
- 1 January 2015
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 4 (1) , 36-45
Cellular response to the genotoxic insult: the question of threshold for genotoxic carcinogens
Maintenance of cellular integrity is crucial for its physiological function, which is constantly threatened by DNA damage arising from numerous intrinsic and environmental sources.
- 1 January 2015
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 4 (1) , 36-45
Open AccessCellular response to the genotoxic insult: the question of threshold for genotoxic carcinogens
Maintenance of cellular integrity is crucial for its physiological function, which is constantly threatened by DNA damage arising from numerous intrinsic and environmental sources.
- 24 April 2012
- Published by Royal Society of Chemistry (RSC)
- p. 1-20
Introduction and Conclusion: The Rationale for Thresholds for Genotoxic Carcinogens
Maintenance of the cellular integrity is crucial for its physiological function, which is constantly threatened by DNA damage arising from numerous intrinsic and environmental sources. Intracellular detoxification mechanisms protect from mutagenic consequences of endogenously produced DNA-reactive carcinogens to keep them at physiological concentrations by detoxifying enzymes, which also applies for exogenous genotoxins. Mild DNA damage normally is managed by DNA repair including impairment of cell proliferation to enhance repair efficiency. More severe or irreparable DNA damage trigger the induction of cell death programmes such as apoptosis or necrosis. Assuming that there is no specific qualitative difference between the background and the chemical induced DNA damage, a small additional amount of DNA damage should be equally efficiently repaired and would not lead to an increase in mutations. The background steady-state level of DNA damage is about 500 base alterations per cell, which corresponds to about one lesion per 106 bases and is much lower than the approximately 18 000 base losses or abasic sites per cell formed each day. This illustrates a remarkable efficiency of the DNA repair mechanism. The increasing knowledge about the cellular defence makes it unlikely that low exposure of genotoxic chemicals, which insignificantly affect the background rate of DNA damage, impair cellular homeostasis. Thus, a threshold for genotoxic carcinogens a threshold is a reasonable and practical assumption, given the current wealth of biological information presented in this book. Moreover, high experimental exposures will overwhelm any cellular defence mechanism and question the relevance of data from high dose animal studies for much lower human exposures.
- 24 April 2012
- Published by Royal Society of Chemistry (RSC)
- p. 1-20
Introduction and Conclusion: The Rationale for Thresholds for Genotoxic Carcinogens
Maintenance of the cellular integrity is crucial for its physiological function, which is constantly threatened by DNA damage arising from numerous intrinsic and environmental sources. Intracellular detoxification mechanisms protect from mutagenic consequences of endogenously produced DNA-reactive carcinogens to keep them at physiological concentrations by detoxifying enzymes, which also applies for exogenous genotoxins. Mild DNA damage normally is managed by DNA repair including impairment of cell proliferation to enhance repair efficiency. More severe or irreparable DNA damage trigger the induction of cell death programmes such as apoptosis or necrosis. Assuming that there is no specific qualitative difference between the background and the chemical induced DNA damage, a small additional amount of DNA damage should be equally efficiently repaired and would not lead to an increase in mutations. The background steady-state level of DNA damage is about 500 base alterations per cell, which corresponds to about one lesion per 106 bases and is much lower than the approximately 18 000 base losses or abasic sites per cell formed each day. This illustrates a remarkable efficiency of the DNA repair mechanism. The increasing knowledge about the cellular defence makes it unlikely that low exposure of genotoxic chemicals, which insignificantly affect the background rate of DNA damage, impair cellular homeostasis. Thus, a threshold for genotoxic carcinogens a threshold is a reasonable and practical assumption, given the current wealth of biological information presented in this book. Moreover, high experimental exposures will overwhelm any cellular defence mechanism and question the relevance of data from high dose animal studies for much lower human exposures.
- 11 September 2009
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 39 (8) , 695-718
Chemically induced pheochromocytomas in rats: mechanisms and relevance for human risk assessment
Pheochromocytomas are tumors originating from chromaffin cells of the adrenal medulla, which have been observed in numerous carcinogenicity studies. The authors have evaluated pheochromocytoma concurrence with other effects and the possible mechanisms, in order to assess the relevance of such data for the classification of carcinogenic effects and their relevance to humans. The evaluation revealed that pheochromocytomas occur with relatively higher frequency in male rats, especially when the following conditions are involved: hypoxia, uncoupling of oxidative phosphorylation, disturbance in calcium homeostasis, and disturbance of the hypothalamic endocrine axis. The underlying biochemical mechanisms suggest that other substances that interfere with these biochemical endpoints also produce pheochromocytomas. Such endpoints include enzymes involved in catecholamine synthesis, receptor tyrosine kinase (RET), hypoxia-inducible factor (HIF), succinate dehydrogenase, fumarate hydratase, and pyruvate dehydrogenase. To date, there is no indication that the substances inducing pheochromocytomas in animal experiments also induce corresponding tumors in humans. Because the mechanisms of action identified in rats are to be expected in humans, pheochromocytomas may be induced after exposure conditions similar to those used in the animal studies. Whether hereditary mutations represent a risk factor in humans is not clear. Pheochromocytomas that occur in animal experiments currently appear to have little relevance for conditions at the work place. When sufficiently documented and evaluated, such secondary pheochromocytomas are not relevant for classification and human risk assessment.
- 11 September 2009
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 39 (8) , 695-718
Chemically induced pheochromocytomas in rats: mechanisms and relevance for human risk assessment
Pheochromocytomas are tumors originating from chromaffin cells of the adrenal medulla, which have been observed in numerous carcinogenicity studies. The authors have evaluated pheochromocytoma concurrence with other effects and the possible mechanisms, in order to assess the relevance of such data for the classification of carcinogenic effects and their relevance to humans. The evaluation revealed that pheochromocytomas occur with relatively higher frequency in male rats, especially when the following conditions are involved: hypoxia, uncoupling of oxidative phosphorylation, disturbance in calcium homeostasis, and disturbance of the hypothalamic endocrine axis. The underlying biochemical mechanisms suggest that other substances that interfere with these biochemical endpoints also produce pheochromocytomas. Such endpoints include enzymes involved in catecholamine synthesis, receptor tyrosine kinase (RET), hypoxia-inducible factor (HIF), succinate dehydrogenase, fumarate hydratase, and pyruvate dehydrogenase. To date, there is no indication that the substances inducing pheochromocytomas in animal experiments also induce corresponding tumors in humans. Because the mechanisms of action identified in rats are to be expected in humans, pheochromocytomas may be induced after exposure conditions similar to those used in the animal studies. Whether hereditary mutations represent a risk factor in humans is not clear. Pheochromocytomas that occur in animal experiments currently appear to have little relevance for conditions at the work place. When sufficiently documented and evaluated, such secondary pheochromocytomas are not relevant for classification and human risk assessment.